This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2018-2023.
Location History:
- Tsukuba, JP (2022)
- Gifu, JP (2018 - 2023)
Company Filing History:
Years Active: 2018-2023
Title: Kanta Horie: Innovator in Pharmaceutical Formulations
Introduction
Kanta Horie is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 3 patents. His work focuses on improving the stability and efficacy of various pharmaceutical compounds.
Latest Patents
Horie's latest patents include a lyophilized formulation of hepatic growth factor (HGF). This invention aims to provide a formulation with improved storage stability compared to conventional options. The formulation comprises a hepatic growth factor, trehalose, and a selection of compounds such as arginine and histidine. Another significant patent is a pharmaceutical composition that includes a PDE9 inhibitor, specifically designed to enhance therapeutic outcomes.
Career Highlights
Kanta Horie is currently associated with Eisai R&D Management Co., Ltd. His innovative work in pharmaceutical formulations has positioned him as a key figure in the industry. His patents reflect a commitment to advancing medical science and improving patient care.
Collaborations
Horie collaborates with talented individuals such as Ryo Ohori and Edgar Schuck. These partnerships enhance the research and development efforts within his team.
Conclusion
Kanta Horie's contributions to pharmaceutical formulations demonstrate his dedication to innovation in the medical field. His patents not only showcase his expertise but also have the potential to significantly impact patient treatment options.